1. 1In: Belknap JK, Moore JN editor. Special Issue: Inflammatory aspects of equine laminitis. Vet Immunol Immunopath. 129:2009;p. 149–262.
2. 2Weiss DJ, Evanson OA, McClenahan D, Fagliari JJ, Jenkins K. Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis. Am J Vet Res. 1997;58:1376–1380. MEDLINE
3. 3Eades SC, Stokes AM, Johnson PJ, LeBlanc CJ, Ganjam VK, Buff PR, et al. Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload. Am J Vet Res. 2007;68:87–94. MEDLINE |
CrossRef
4. 4Weiss DJ, Evanson OA, McClenahan D, Fagliari JJ, Dunnwiddie CT, Wells RE. Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am J Vet Res. 1998;59:814–817. MEDLINE
5. 5Black SJ, Lunn DP, Yin C, Hwang M, Lenz SD, Belknap JK. Leukocyte emigration in the early stages of laminitis. Vet Immunol Immunopath. 2006;109:161–166.
6. 6Hurley DJ, Parks RJ, Reber AJ, Donovan DC, Okinaga T, Vandenplas ML, et al. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Vet Immunol Immunopath. 2006;110:195–206.
7. 7Riggs LM, Franck T, Moore JN, Krunkosky TM, Hurley DJ, Peroni JF, et al. Neutrophil myeloperoxidase measurements in plasma, laminar tissue, and skin of horses given black walnut extract. Am J Vet Res. 2007;68:81–86. MEDLINE |
CrossRef
8. 8Loftus JP, Belknap JK, Black SJ. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet Immunol Immunopath. 2006;113:267–276.
9. 9Stewart AJ, Pettigrew A, Cochran AM, Belknap JK. Indices of inflammation in the lung and liver in the early stages of the black walnut extract model of equine laminitis. Vet Immunol Immunopath. 2009;129:254–260.
10. 10Faleiros RR, Nuovo GJ, Belknap JK. Calprotectin in myeloid and epithelial cells of laminae from horses with black walnut extract-induced laminitis. J Vet Intern Med. 2009;23:174–181.
CrossRef
11. 11Faleiros RR, Stokes AM, Eades SC, Kim DY, Paulsen DB, Moore RM. Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis. Am J Vet Res. 2004;65:578–585. MEDLINE |
CrossRef
12. 12Pollitt CC, Daradka M. Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine Vet J Suppl. 1998;26:139–144.
13. 13Pollitt CC. Equine laminitis: a revised pathophysiology. Proc Am Assoc Equine Pract. 1999;45:188–192.
14. 14Mungall BA, Pollitt CC. Zymographic analysis of equine laminitis. Histochem Cell Biol. 1999;112:467–472. MEDLINE
15. 15Johnson PJ, Kreeger JM, Keeler M, Ganjam VK, Messer NT. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis. Equine Vet J. 2000;32:462–468. MEDLINE |
CrossRef
16. 16Kyaw-Tanner M, Pollitt CC. Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine Vet J. 2004;36:221–225. MEDLINE |
CrossRef
17. 17Kyaw-Tanner MT, Wattle O, van Eps AW, Pollitt CC. Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset. Equine Vet J. 2008;40:482–487.
CrossRef
18. 18Loftus JP, Johnson PJ, Belknap JK, Pettigrew A, Black SJ. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopath. 2009;129:221–230.
19. 19Coyne MJ, Cousin H, Loftus JP, Johnson PJ, Belknap JK, Gradil CM, et al. Cloning and expression of ADAM-related metalloproteases in equine laminitis. Vet Immunol Immunopath. 2009;129:231–241.
20. 20Budak M, Orsini JA, Pollitt C, Rubinstein N. Gene expression in the lamellar dermis-epidermis during the developmental phase of carbohydrate overload-induced laminitis in the horse. Vet Immunol and Immunopath. 2009;131:86–96.
21. 21Fontaine GL, Belknap JK, Allen D, Moore JN, Kroll DL. Expression of interleukin-1beta in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. Am J Vet Res. 2001;62:714–720. MEDLINE |
CrossRef
22. 22Waguespack RW, Kemppainen RJ, Cochran A, Lin HC, Belknap JK. Increased expression of MAIL, a cytokine-associated nuclear protein, in the prodromal stage of black walnut-induced laminitis. Equine Vet J. 2004;36:285–291. MEDLINE |
CrossRef
23. 23Belknap JK, Giguère S, Pettigrew A, Cochran AM, Van Eps AW, Pollitt CC. Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response. Equine Vet J. 2007;39:42–47. MEDLINE |
CrossRef
24. 24Loftus JP, Belknap JK, Stankiewicz KM, Black SJ. Laminar xanthine oxidase, superoxide dismutase and catalase activities in the prodromal stage of black-walnut induced equine laminitis. Equine Vet J. 2007;39:48–53. MEDLINE |
CrossRef
25. 25Noschka E, Vandenplas ML, Hurley DJ, Moore JN. Temporal aspects of laminar gene expression during the developmental stages of equine laminitis. Vet Immunol Immunopath. 2009;129:242–253.
26. 26Blikslager AT, Yin C, Cochran AM, Wooten JG, Pettigrew A, Belknap JK. Cyclooxygenase expression in the early stages of equine laminitis: a cytologic study. J Vet Intern Med. 2006;20:1191–1196. MEDLINE |
CrossRef
27. 27Yin C, Pettigrew A, Loftus JP, Black SJ, Belknap JK. Tissue concentrations of 4-HNE in the black walnut extract model of laminitis: indication of oxidant stress in affected laminae. Vet Immunol Immunopath. 2009;129:211–215.
28. 28Carter RA, Treiber KH, Geor RJ, Douglass L, Harriss PJ. Prediction of incipient pasture associated laminitis from hyperinsulinaemia, hyperleptinaemia, and generalized obesity in a cohort of ponies. Equine Vet J. 2009;41:171–178.
CrossRef
29. 29Bailey SR, Habershon-Butcher JL, Ransom KJ, Elliott J, Menzies-Gow MJ. Hypertension and insulin resistance in a mixed breed population of ponies predisposed to laminitis. Am J Vet Res. 2008;69:122–129.
CrossRef
30. 30Treiber K, Carter R, Gay L, Williams C, Geor R. Inflammatory and redox status of ponies with a history of pasture-associated laminitis. Vet Immunol Immunopath. 2009;129:216–220.
31. 31Robertson TP, Bailey SR, Peroni JF. Equine laminitis: a journey to the dark side of venous. Vet Immuno Immunopath. 2009;129:164–166.
32. 32Allen D, Clark ES, Moore JN, Prasse KW. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res. 1990;51:1930–1934. MEDLINE
33. 33Eaton SA, Allen D, Eades SC, Schneider DA. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Am J Vet Res. 1995;56:1338–1344. MEDLINE
34. 34Eades SC, Stokes AM, Moore RM. Effects of an endothelin receptor antagonist and nitroglycerin on digital vascular function in horses during the prodromal stages of carbohydrate overload-induced laminitis. Am J Vet Res. 2006;67:1204–1211. MEDLINE |
CrossRef
35. 35Keen JA, Hillier C, McGorum BC, Nally JE. Endothelin mediated contraction of equine laminar veins. Equine Vet J. 2008;40:488–492.
CrossRef
36. 36Bailey SR, Marr CM, Elliott J. Identification and quantification of amines in the equine caecum. Res Vet Sci. 2003;74:113–118. MEDLINE |
CrossRef
37. 37Geor R, Frank N. Metabolic syndrome—from human organ disease to laminar failure in equids. Vet Immunol Immunopath. 2009;129:151–154.